MEA Musculoskeletal Diseases Market

The size of the Middle East and Africa Musculoskeletal Diseases Market is expected to grow at a sluggish CAGR between 2022 to 2027. The Middle East and Africa Musculoskeletal Diseases market is developing at an exceptionally quick pace.

Musculoskeletal diseases are injuries/pain in the human musculoskeletal system, which also includes the joints, muscles, nerves, tendons, ligaments, and structures that support limbs, neck and back. These are caused by sudden exertion, or they can arise from making the same motions repeatedly. With increasing age the risk of musculoskeletal diseases increases. Also, obese people have high risk of musculoskeletal diseases.

The significant drivers are increase in prevalence of musculoskeletal disorders. Factors like unmet medical needs in developing nations and growing need of drugs related to bones will boost this industry.

The Middle East and Africa Musculoskeletal Diseases market is segmented on the basis of Type, Type of Molecules and region. Based on Type the market is segmented into Rheumatoid arthritis, osteoarthritis, osteoporosis, psoriatic arthritis, ankylosing spondylitis, fibromyalgia, and others. Rheumatoid arthritis has high prevalence and therefore has the largest market share. Based on Type of molecules the market is segmented into biologics and small molecules. Biologics is expected to have the largest market share. Biologics have complex structure which does not allow easy identification or characterization which is driving this segment.

Geographically, market is further segmented into Middle East and Africa. Middle East and Africa has an untapped market and key players are slowly expanding to this region which is the main reason for the growth of market in this region.

AbGenomics International, AB Sciences, Ablynx, Akron Molecules, Johnson & Johnson, F. Hoffmann-La Roche, Pfizer,Eli Lilly, Adheron, Alder BioPharmaceuticals, Bioiberica, Bone Therapeutics, Edding Pharm, Boehringer Ingelheim, Can-Fite BioPharma, Celltrion, Celgene Corp., Cellular Biomedicine, ChemoCentryx, Cerapedics, , Eupraxia Pharmaceuticals, and GlaxoSmithKline are the some of the key players  in the Middle East and Africa Musculoskeletal Diseases market.